Signals
Astrazeneca Pharma India Ltd
NSE :ASTRAZEN BSE :506820 Sector : PharmaceuticalsBuy, Sell or Hold ASTRAZEN? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
| 17 Mar 7712.40 (0.48%) | 13 Mar 7675.55 (-0.41%) | 12 Mar 7706.85 (-1.29%) | 11 Mar 7807.35 (2.38%) | 10 Mar 7625.60 (2.11%) | 07 Mar 7468.15 (0.02%) | 06 Mar 7466.65 (1.73%) | 05 Mar 7339.45 (0.45%) | 04 Mar 7306.25 (6.53%) | 03 Mar 6858.20 (2.38%) | 28 Feb 6698.65 (-2.78%) | 27 Feb 6890.45 (-0.42%) | 25 Feb 6919.30 (0.36%) | 24 Feb 6894.45 (0.35%) | 21 Feb 6870.30 (-1.51%) | 20 Feb 6975.80 (0.18%) | 19 Feb 6963.15 (-0.20%) | 18 Feb 6977.30 (-0.43%) | 17 Feb 7007.75 (-1.35%) | 14 Feb 7103.65 (-3.94%) | 13 Feb 7395.05 (-1.38%) |
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Very Bullish
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bullish
7699.55
10 DMA
Bullish
7490.72
20 DMA
Bullish
7209
50 DMA
Bullish
7189.5
100 DMA
Bullish
7025.24
200 DMA
Bullish
6927.94
Intraday Support and Resistance
(Based on Pivot Points) undefined |
Updated On Mar 17, 2025 04:00 PM For Next Trading Session
| Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
|---|---|---|---|---|---|
| R3 | 8070.1 | 7968.4 | 7775.57 | - | - |
| R2 | 7968.4 | 7880.65 | 7754.51 | 7961.83 | - |
| R1 | 7840.4 | 7826.45 | 7733.46 | 7827.26 | 7904.4 |
| P | 7738.7 | 7738.7 | 7738.7 | 7732.13 | 7770.7 |
| S1 | 7610.7 | 7650.95 | 7691.34 | 7597.56 | 7674.7 |
| S2 | 7509 | 7596.75 | 7670.29 | 7502.43 | - |
| S3 | 7381 | 7509 | 7649.23 | - | - |
Key Metrics
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Astrazeneca Pharma India Ltd Quaterly Results
| INCOME | |
| PROFIT | |
| EPS |
Astrazeneca Pharma India Ltd Quaterly Results
| INCOME | 315.45 | 391.86 | 395.87 | 416.15 | 448.27 | |
| PROFIT | 15.8 | 39.48 | 35.02 | 38.43 | 54.68 | |
| EPS | 6.32 | 15.79 | -4.72 | 16.37 | 12.34 |
Profit & Loss (Figures in Rs. Crores)
Astrazeneca Pharma India Ltd Profit & Loss
| INCOME | |
| PROFIT | |
| EPS |
Astrazeneca Pharma India Ltd Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
| INCOME | 516.91 | 565.08 | 540.12 | 634.25 | 745.96 | 884.01 | 823.45 | 805.89 | 1077.93 | 1380.53 | |
| PROFIT | -20.84 | 5.22 | 15.77 | 25.9 | 54.41 | 72.03 | 91.72 | 59.55 | 126.25 | 149.06 | |
| EPS | 0 | 2.1 | 8.02 | 10.36 | 21.78 | 28.88 | 37.32 | 24.64 | 39.72 | 64.6 |
Balance Sheet (Figures in Rs. Crores)
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
| SOURCES OF FUNDS : | ||||||||||
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves Total | 706.92 | 583.69 | 506.39 | 451.17 | 359.44 | 295.8 | 241.93 | 217.87 | 151.01 | 145.76 |
| Total Shareholders Funds | 711.92 | 588.69 | 511.39 | 456.17 | 364.44 | 300.8 | 246.93 | 222.87 | 156.01 | 150.76 |
| Unsecured Loans | 4.59 | 7.21 | 8.63 | 12.14 | 11.84 | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 4.59 | 7.21 | 8.63 | 12.14 | 11.84 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 6.21 | 8.56 | 7.5 | 6.41 | 5.38 | 2.02 | 6.66 | 2.28 | 12.92 | 1.02 |
| Total Liabilities | 722.72 | 604.46 | 527.52 | 474.72 | 381.66 | 302.82 | 253.59 | 225.15 | 168.93 | 151.78 |
| APPLICATION OF FUNDS : | ||||||||||
| Gross Block | 187.13 | 179.12 | 168.83 | 159.78 | 132.84 | 119.83 | 105.85 | 102.57 | 203.76 | 191.44 |
| Less : Accumulated Depreciation | 120.45 | 110.26 | 94.34 | 78.82 | 61.31 | 45 | 30.39 | 15.73 | 106.4 | 90.46 |
| Net Block | 66.68 | 68.86 | 74.49 | 80.96 | 71.53 | 74.83 | 75.46 | 86.84 | 97.36 | 100.98 |
| Capital Work in Progress | 0.27 | 1.33 | 2.2 | 4.02 | 24.24 | 6.9 | 3.57 | 4.81 | 6.31 | 12.21 |
| Inventories | 227.88 | 190.21 | 140.22 | 159.8 | 165.15 | 118.1 | 113.15 | 57.71 | 76.73 | 86.13 |
| Sundry Debtors | 153.13 | 107.52 | 85.89 | 85.19 | 83.21 | 79.75 | 54.63 | 43 | 83.14 | 42.77 |
| Cash and Bank Balance | 505.84 | 500.48 | 448.46 | 352.35 | 252.52 | 173.3 | 125.92 | 115.58 | 76.83 | 25.08 |
| Loans and Advances | 45.86 | 37.26 | 31.1 | 21.42 | 41.44 | 33.57 | 27.22 | 35.26 | 30.37 | 109.27 |
| Total Current Assets | 932.71 | 835.47 | 705.67 | 618.76 | 542.32 | 404.72 | 320.92 | 251.55 | 267.07 | 263.26 |
| Current Liabilities | 305.23 | 336.31 | 281.06 | 257.44 | 278.24 | 222.58 | 166.61 | 157.5 | 215.71 | 222.87 |
| Provisions | 50.08 | 44.1 | 47.98 | 42.55 | 46.46 | 36.4 | 40.34 | 32.84 | 18.33 | 36.95 |
| Total Current Liabilities & Provisions | 355.31 | 380.41 | 329.04 | 299.99 | 324.7 | 258.98 | 206.95 | 190.34 | 234.05 | 259.82 |
| Net Current Assets | 577.4 | 455.06 | 376.63 | 318.77 | 217.62 | 145.74 | 113.97 | 61.21 | 33.03 | 3.44 |
| Deferred Tax Assets | 22.31 | 22.2 | 18.17 | 17.31 | 17.47 | 24.42 | 34.32 | 43.56 | 0 | 0 |
| Deferred Tax Liability | 1.06 | 1.53 | 1.87 | 2.78 | 2.83 | 1.06 | 1.77 | 3.34 | 0 | 0 |
| Net Deferred Tax | 21.25 | 20.67 | 16.3 | 14.53 | 14.64 | 23.36 | 32.55 | 40.22 | 0 | 0 |
| Other Assets | 57.12 | 58.54 | 57.9 | 56.44 | 53.63 | 51.99 | 28.04 | 32.07 | 32.24 | 35.14 |
| Total Assets | 722.72 | 604.46 | 527.52 | 474.72 | 381.66 | 302.82 | 253.59 | 225.15 | 168.94 | 151.77 |
| Contingent Liabilities | 137.64 | 131.62 | 121.37 | 85.66 | 67.33 | 26.77 | 7.34 | 15.97 | 16.62 | 12.26 |
Cash Flow (Figures in Rs. Crores)
| Net Profit before Tax and Extr... | 219.54 |
| Depreciation | 14.94 |
| Interest (Net) | -31.37 |
| P/L on Sales of Assets | -0.03 |
| Prov. and W/O (Net) | 6.5 |
| P/L in Forex | 0.15 |
| Total Adjustments (PBT and Ext... | -7.07 |
| Operating Profit before Workin... | 212.47 |
| Trade and 0ther Receivables | -51.18 |
| Inventories | -37.67 |
| Trade Payables | -31.37 |
| Loans and Advances | 0.56 |
| Total Adjustments (OP before W... | -128.17 |
| Cash Generated from/(used in) ... | 84.3 |
| Direct Taxes Paid | -56.43 |
| Total Adjustments(Cash Generat... | -56.43 |
| Cash Flow before Extraordinary... | 27.87 |
| Net Cash from Operating Activi... | 27.87 |
| Purchased of Fixed Assets | -10.76 |
| Sale of Fixed Assets | 0.41 |
| Interest Received | 32.09 |
| Net Cash used in Investing Act... | 21.74 |
| Of Financial Liabilities | -3.86 |
| Dividend Paid | -40 |
| Interest Paid | -0.52 |
| Net Cash used in Financing Act... | -44.38 |
Company Details
Registered Office |
|
| Address | Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road |
| City | Bangalore |
| State | Karnataka |
| Pin Code | 560045 |
| Tel. No. | 91-080-67748000 |
| Fax. No. | 91-080-67748557 |
| comp.secy@astrazeneca.com | |
| Internet | http://www.astrazeneca.in |
Registrars |
|
| Address | Blk N1 12th Flr Manyata Embass |
| City | Bangalore |
| State | Karnataka |
| Pin Code | 560045 |
| Tel. No. | 91-080-67748000 |
| Fax. No. | 91-080-67748557 |
| comp.secy@astrazeneca.com | |
| Internet | http://www.astrazeneca.in |
Management |
|
| Name | Designation |
| Narayan K Seshadri | Chairman & Independent Directo |
| Revathy Ashok | Non-Exec. & Independent Dir. |
| Shilpa Divekar Nirula | Non-Exec. & Independent Dir. |
| Sanjeev Panchal | Managing Director |
| Hooi Bien Chuah | Non Executive Director |
| Sylvia Lorena Varela Ramon | Non Executive Director |
| Bhavana Agrawal | Executive Director |
